Add BrightSurf on Google Email

Texas Heart Institute presents paradigm-shifting, late-breaking heart failure therapy research at the American Heart Association annual meeting

Researchers at the Texas Heart Institute have made significant breakthroughs in treating persistent heart failure with a novel stem cell therapy. The phase 3 clinical trial results show that this treatment has the potential to alter the natural history of heart disease, reducing hospitalizations and improving patient outcomes.

SourceTexas Heart Institute·TypeExperimental study·DateNov 15, 2021

Penicillin slows devastating impacts of rheumatic heart disease in children from Uganda

A large-scale trial found that penicillin can prevent progression of latent rheumatic heart disease in Ugandan children. The study enrolled 818 children and showed that early detection coupled with prophylactic treatment significantly reduced worsened heart conditions, offering hope for addressing this neglected disease.

SourceChildren's National Hospital·JournalNew England Journal of Medicine·TypeRandomized controlled/clinical trial·DateNov 13, 2021

The Lancet Global Health: Treatment of COVID-19 with fluvoxamine reduces risk of prolonged hospitalization, finds largest trial to date

The largest trial to date shows that fluvoxamine treatment for high-risk outpatients with early-diagnosed COVID-19 reduces the need for prolonged observation or hospitalization. The study found an absolute reduction in risk of prolonged hospitalization and a relative risk reduction of 32% compared to the control group.

SourceThe Lancet·JournalThe Lancet Global Health·TypeRandomized controlled/clinical trial·DateOct 27, 2021

Addition of genotypic resistance testing did not improve virologic response in patients with HIV virologic failure sub-Saharan Africa

A randomized controlled trial found that adding genotypic resistance testing to routine care didn't improve virologic suppression among HIV patients with first-line antiretroviral therapy failure in public-sector clinics in Uganda and South Africa. The findings highlight the need for effective interventions for persons with virologic f...

SourceAmerican College of Physicians·JournalAnnals of Internal Medicine·TypeRandomized controlled/clinical trial·DateOct 25, 2021

Grieving spouses should focus on the body, study suggests

A new study published in the Journal of Consulting and Clinical Psychology found that a six-week progressive muscle relaxation program significantly improved grief severity and yearning in widows and widowers. This approach was more effective than mindfulness training, which also showed improvements but not to the same extent.

SourceUniversity of Arizona·JournalJournal of Consulting and Clinical Psychology·TypeRandomized controlled/clinical trial·DateAug 18, 2021

Analyzing legislative engagement

A randomized controlled trial found that Congressional offices with targeted support reported increased value of scientific evidence for understanding legislative issues. The intervention group introduced around 23% more bills using research evidence language and reported a 7% greater value of using research evidence compared to controls.

SourceProceedings of the National Academy of Sciences·JournalProceedings of the National Academy of Sciences·DateFeb 15, 2021

Vitamin D lessens symptoms of severe eczema in children

A randomized controlled trial found that vitamin D supplementation improved clinical outcomes for children with severe atopic dermatitis. The study involved 86 patients who received either oral daily vitamin D or placebo for 12 weeks.

SourceWiley·JournalPharmacology Research & Perspectives·DateNov 4, 2020

Gamifying interventions may improve mental health

A new randomized control trial found that gamifying mobile mental health intervention content improved resilience and reduced attrition. The study showed significant benefits in both resilience and anxiety measurements after five weeks, with the game group retaining 21% more participants than other groups.

SourcePLOS·JournalPLOS ONE·DateSep 2, 2020

New analysis shows hydroxychloroquine does not lower mortality in COVID-19 patients, and is associated with increased mortality when combined with the antibiotic azithromycin

A new meta-analysis of published studies on hydroxychloroquine for COVID-19 treatment finds no mortality benefit, while combining it with azithromycin is associated with a 27% increased risk. The study supports current clinical recommendations against using these drugs for COVID-19 patients.

SourceEuropean Society of Clinical Microbiology and Infectious Diseases·JournalClinical Microbiology and Infection·DateAug 26, 2020

Text messaging: The next gen of therapy in mental health

A new study found that texting intervention as an add-on to mental health treatment programs improved symptoms and increased participant engagement. The research team developed a text-messaging-based psychotherapy tool that was clinically promising, safe, and feasible for people with serious mental illness.

SourceDartmouth College·JournalPsychiatric Services·DateJul 28, 2020

Improving lung cancer CT screening performance in real-world settings

The study found that focusing on subjects less likely to remain in the program, such as smokers and those with negative low-dose CT exams, improves cost-effectiveness and maximizes societal benefits. Adherence increased progressively with higher Lung-RADS categories, and having smoked previously was a significant predictor of adherence.

SourceAmerican Roentgen Ray Society·JournalAmerican Journal of Roentgenology·DateJul 16, 2020

Arthritis clinical trial shows support for dextrose injection to alleviate knee pain

A randomized controlled trial found that intra-articular hypertonic dextrose injections significantly reduced knee pain in patients with moderate to severe osteoarthritis. The study, conducted at the Chinese University of Hong Kong, involved 76 patients who received either the hypertonic dextrose or normal saline injection therapy.

SourceAmerican Academy of Family Physicians·JournalThe Annals of Family Medicine·DateMay 12, 2020

The Lancet Rheumatology: Small observational study of patients with severe COVID-19 treated with the arthritis drug anakinra finds clinical improvements

A small observational study of 29 Italian patients with severe COVID-19 and hyperinflammation found that high-dose intravenous anakinra was associated with respiratory improvements and reduced signs of cytokine storm in 72% of patients. The treatment was generally safe, but more research is needed to fully understand its effectiveness.

SourceThe Lancet·JournalThe Lancet Rheumatology·DateMay 7, 2020

Green tea may help with weight loss efforts

A study of randomized controlled trials found that consuming green tea led to a significant decline in body weight and body mass index. However, the analysis did not reveal any notable changes in waist circumference after supplementation.

SourceWiley·JournalPhytotherapy Research·DateMay 6, 2020

Workplace program to improve blood pressure control

A randomized clinical trial in 60 urban workplaces in China found that a wellness program with hypertension management component significantly improved blood pressure control among employees. The program reduced systolic blood pressure by 3.5 mmHg and diastolic blood pressure by 2.5 mmHg compared to usual care.

SourceJAMA Network·JournalJAMA Cardiology·DateMar 4, 2020

Special issue of Educational Researcher examines the nature and consequences of null findings

A newly released special issue examines the prevalence of null findings in randomized control trials, highlighting their expected and valuable role in evaluation research. Key articles propose frameworks for defining and interpreting null results, exploring context and implementation fidelity as factors influencing outcomes.

SourceAmerican Educational Research Association·JournalEducational Researcher·DateDec 17, 2019

The Lancet journals: Papers at ERS Congress 2019

The Lancet Respiratory Medicine published a series of papers on cystic fibrosis treatment, including new CFTR modulator drugs showing promise and improving patient outcomes. Additionally, a three-in-one inhaler therapy was found to improve lung function and reduce asthma attacks in patients with severe asthma.

SourceThe Lancet·JournalThe Lancet Respiratory Medicine·DateSep 30, 2019

Public attitudes toward police

Researchers conducted a randomized controlled trial in New Haven, Connecticut, where police officers made community policing visits to residents' homes. The study found that positive interactions improved public trust and cooperation with police, especially among black individuals and those with strong negative views towards the police.

SourceProceedings of the National Academy of Sciences·JournalProceedings of the National Academy of Sciences·DateSep 16, 2019

The Lancet journals: Papers at ESC Congress 2019

The Lancet published several studies on cardiovascular disease, including a new risk chart for 21 global regions and a trial on percutaneous coronary intervention versus coronary artery bypass grafting. Additionally, the journal presented findings on sirolimus-eluting stents versus durable polymer everolimus-eluting stents in patients ...

SourceThe Lancet·JournalThe Lancet·DateSep 3, 2019

Mount Sinai study reports asthma control in older patients and shows lower ED visits

A Mount Sinai study found improved asthma control and quality of life in older patients, with a significant reduction in emergency department visits. The study tested a patient-tailored self-management support intervention, which targeted social determinants of health and achieved meaningful improvements.